And this is addressing the company, in what way?
Post# of 9144
Posted On: 11/11/2014 8:28:45 AM
And this is addressing the company, in what way? As (apparently) a brand new poster on this board or one emboldened by a new identity it is intriguing that you feel comfortable going after the regular posters as your first offering.
In any event, I agree with Microcaps that we should focus on the company. Please do so and enlighten the rest of us about your perspectives on the company. I, and I am certain numerous others, are on the edge of our seats. What, for example, do you think about the potential of the N-Assay in either the bacterial or viral context? How do you think NanoLogix should better work to penetrate the US and European medical diagnostic markets? What are the best ways to develop the Third World markets through the WHO/UN auspices and who are the best people to contact about that? These are just a few potential contributions you might make that might be more useful than seeking to operate as a grade school hall monitor checking passes. So, how does NanoLogix become better?
In any event, I agree with Microcaps that we should focus on the company. Please do so and enlighten the rest of us about your perspectives on the company. I, and I am certain numerous others, are on the edge of our seats. What, for example, do you think about the potential of the N-Assay in either the bacterial or viral context? How do you think NanoLogix should better work to penetrate the US and European medical diagnostic markets? What are the best ways to develop the Third World markets through the WHO/UN auspices and who are the best people to contact about that? These are just a few potential contributions you might make that might be more useful than seeking to operate as a grade school hall monitor checking passes. So, how does NanoLogix become better?
(0)
(0)